Monsanto Growth Ventures has co-led the first round disclosed by Pairwise Plants, an agricultural gene-editing company based on Harvard University research.
Pairwise Plants, a US-based agricultural gene editing technology developer exploiting Harvard University research, closed a $25m series A round on Tuesday co-led by Monsanto Growth Ventures, a corporate venturing subsidiary of agrochemical producer Monsanto.
The round was co-led with healthcare-focused investment firm Deerfield Management. The company has not previously disclosed funding.
Founded in 2017, Pairwise is working on agricultural gene modification technology to help alleviate pressures in the global food chain. It will look to partner companies working with produce…
